German Telecom Services and Carriers Stock News

XTRA:GXI
XTRA:GXILife Sciences

Assessing Gerresheimer (XTRA:GXI) After A Sharp Pre Market Drop Ahead Of Earnings

What triggered the sudden move in Gerresheimer (XTRA:GXI)? Gerresheimer (XTRA:GXI) drew attention after a pre market move of more than 70% on low trading volume, just days ahead of its scheduled earnings release on 26 February 2026. See our latest analysis for Gerresheimer. That sharp pre market swing sits against a weak backdrop, with a 30 day share price return of 31.6% decline and a 1 year total shareholder return of 77.3% decline, suggesting momentum has been fading and market risk...
XTRA:RWE
XTRA:RWERenewable Energy

How RWE’s Norfolk Vanguard West Turbine Deal and KKR Partnership Will Impact RWE (XTRA:RWE) Investors

RWE has recently placed a firm order with Vestas for 92 V236-15.0 MW turbines for the 1,380 MW Norfolk Vanguard West offshore wind project in the UK, following its successful award of a Contract for Difference in Allocation Round 7 and targeting final investment decision in summer 2026 with commissioning in 2029. This contract, alongside KKR acquiring a 50% stake in the Norfolk Vanguard projects, underscores how RWE is advancing capital-light partnerships to expand its offshore wind...
XTRA:HOT
XTRA:HOTConstruction

A Look At HOCHTIEF’s (XTRA:HOT) Valuation As Earnings Rise And The Dividend Jumps 26%

Why HOCHTIEF’s latest earnings and dividend move matter for shareholders HOCHTIEF (XTRA:HOT) has caught investor attention after reporting 2025 results with higher sales and net income, announcing a 26% dividend increase to €6.60 per share, and issuing upgraded operational net profit guidance for 2026. The company reported 2025 sales of €38,236.46m compared with €33,301.27m a year earlier, while net income reached €902.33m versus €775.63m. Basic earnings per share from continuing operations...
XTRA:EOAN
XTRA:EOANIntegrated Utilities

A Look At E.ON (XTRA:EOAN) Valuation After Higher Earnings And Expanded 2030 Investment Plan

E.ON (XTRA:EOAN) shares are in focus after the company reported higher earnings alongside a raised investment plan running through 2030, highlighting its continued push into European energy infrastructure projects. See our latest analysis for E.ON. The share price has moved to €18.74, with a 30-day share price return of 10.56% and a 90-day share price return of 20.71%. The 1-year total shareholder return of 61.14% and 5-year total shareholder return of 173.98% point to momentum that has built...
XTRA:MBG
XTRA:MBGAuto

Mercedes-Benz Backs Wayve To Align AI Autonomy With Cash Returns

Mercedes-Benz Group (XTRA:MBG) has backed UK-based autonomous driving company Wayve in its substantial Series D funding round. The collaboration focuses on developing and commercializing self-driving solutions using Wayve's AI-driven "embodied intelligence" platform. Mercedes-Benz joins partners such as Uber and Nissan, aligning its premium automotive brand with emerging autonomous mobility technology. For you as an investor, this ties directly into how Mercedes-Benz is positioning its core...
XTRA:MTX
XTRA:MTXAerospace & Defense

MTU Aero Engines Record Results Raise Dividend And Test Cash Priorities

MTU Aero Engines (XTRA:MTX) reported record results for 2025, according to its latest update. The company announced a substantial dividend increase for shareholders. Management issued an optimistic 2026 outlook, pointing to strong demand and progress in its GTF program. MTU also highlighted ongoing expansion in its maintenance capabilities as part of its growth plans. MTU Aero Engines, listed as XTRA:MTX, is a key supplier in civil aerospace with a focus on engine programs such as the GTF...
XTRA:BAS
XTRA:BASChemicals

Assessing BASF (XTRA:BAS) Valuation As Recent Returns Send Mixed Signals

Recent performance snapshot for BASF BASF (XTRA:BAS) has been flat over the past day, with a 3.5% decline over the past week, a 6% gain over the past month, and roughly 9.5% over the past 3 months. Over longer periods, the stock shows a 9.1% gain year to date and a 5.6% total return over the past year, alongside a 22.5% total return over 3 years and a 5% total return decline over 5 years. See our latest analysis for BASF. At a share price of €48.87, BASF has paired a 6% 30 day share price...
XTRA:AFX
XTRA:AFXMedical Equipment

Is Carl Zeiss Meditec (XTRA:AFX) Offering Opportunity After A 52% One Year Share Price Slump

If you are wondering whether Carl Zeiss Meditec is starting to look like value after a tough run, this article will walk you through what the current share price might be implying. The stock has faced heavy pressure, with returns of a 1.7% decline over 7 days, a 6.4% decline over 30 days, a 33.0% decline year to date and a 52.4% decline over 1 year, plus a 78.4% decline over 3 years and 77.8% over 5 years. Recent coverage has focused on the company as a key player in medical technology and...
XTRA:DTE
XTRA:DTETelecom

A Look At Deutsche Telekom (XTRA:DTE) Valuation After Its Recent Share Price Strength

Context for Deutsche Telekom’s Recent Share Performance Deutsche Telekom (XTRA:DTE) has drawn investor attention after a strong month, with the share price up about 23%, and a gain of roughly 21% over the past 3 months, prompting closer scrutiny of its fundamentals. See our latest analysis for Deutsche Telekom. That recent 23.1% 1 month share price return, on top of a 19.8% year to date share price return at around €33.32, sits alongside a 3 year total shareholder return of 72.5% and 5 year...
XTRA:VOW3
XTRA:VOW3Auto

Volkswagen Design Shift Under Mindt Raises Questions On Valuation And Demand

Volkswagen (XTRA:VOW3) has appointed Andreas Mindt as the new Group Head of Design. Mindt succeeds Michael Mauer as part of a generational transition in the company’s top design leadership. The move signals a refreshed approach to design at group level across the Volkswagen brands. For an automaker of Volkswagen’s scale, design is not just about looks; it shapes brand identity, pricing power, and how models stand out in crowded segments. As XTRA:VOW3 continues to compete across combustion,...
XTRA:FME
XTRA:FMEHealthcare

Fresenius Medical Care (XTRA:FME) Margin Rebound Tests Bearish Earnings Narratives

Fresenius Medical Care (XTRA:FME) closed out FY 2025 with Q4 revenue of €5.1b and basic EPS of €1.14, as full year trailing twelve month figures showed total revenue of €19.6b and EPS of €3.36. Over the past year, the company has seen quarterly revenue move between about €4.8b and €5.1b, while basic EPS has ranged from €0.52 in Q1 2025 to €1.14 in Q4 2025. This has occurred alongside trailing twelve month net income of €978m, which sits against earlier figures such as €538m at the end of...
XTRA:SMHN
XTRA:SMHNSemiconductor

Has SUSS MicroTec's (XTRA:SMHN) Enlarged Credit Line Quietly Rewritten Its Risk-Reward Profile?

SUSS MicroTec SE recently concluded a new syndicated loan agreement worth €115 million with a five-year term and two optional one-year extensions, replacing its prior €56 million facility that was set to expire in October 2026. By more than doubling its syndicated loan capacity with a consortium of renowned European banks, the company has increased its financial flexibility for general corporate needs and refinancing. Next, we’ll examine how this expanded €115 million syndicated loan...
XTRA:P911
XTRA:P911Auto

Assessing Porsche (XTRA:P911) Valuation As Shares Trade Near €41 With Mixed Recent Returns

Stock context and recent performance snapshot Dr. Ing. h.c. F. Porsche (XTRA:P911) has stayed on investors’ radar after recent trading, with the share price closing at €41.55 and short term returns mixed across the past week and month. Over the past 3 months the stock shows a negative total return, and the 1 year and 3 year total return figures are also negative. This may prompt you to look more closely at how current pricing compares with the company’s earnings and balance sheet. See our...
XTRA:ELG
XTRA:ELGSemiconductor

Assessing Elmos Semiconductor (XTRA:ELG) Valuation After New Buyback Plan And Higher Dividend Proposal

Elmos Semiconductor (XTRA:ELG) has put shareholder returns in focus by approving a share buyback of up to €10.0 million and proposing a 50% dividend increase following its preliminary 2025 results. See our latest analysis for Elmos Semiconductor. The buyback and proposed dividend increase arrive after a strong run in the shares, with the share price at €127.6 and a 30 day share price return of 16.21%, while the 1 year total shareholder return stands at 78.42%, indicating strong positive...
XTRA:BAYN
XTRA:BAYNPharmaceuticals

Assessing Bayer (XTRA:BAYN) Valuation After Mixed Annual Results And Strong Recent Share Returns

Why Bayer (XTRA:BAYN) Is Drawing Investor Attention Now Bayer (XTRA:BAYN) has been on many investors’ radar after a mixed set of figures, with full year revenue of €45.9b alongside a net loss of €198m. This has prompted fresh interest in how the share price reflects this profile. See our latest analysis for Bayer. The mixed full year figures arrive after a 90 day share price return of 38.83% and a 1 year total shareholder return of 93.07%. The 7 day share price return of 6.83% and 30 day...
XTRA:SHL
XTRA:SHLMedical Equipment

Is Siemens Healthineers (XTRA:SHL) Now Attractive After A 22% One Year Share Price Fall

If you are wondering whether Siemens Healthineers is attractively priced at its current level, this article walks through what the numbers suggest and how that might matter for your portfolio. The stock last closed at €41.55, with returns of 1.5% over 7 days, a 4.0% decline over 30 days, a 5.9% decline year to date and a 21.9% decline over 1 year. These moves may catch the eye of investors weighing potential upside against recent share price pressure. Recent news flow around Siemens...
XTRA:IFX
XTRA:IFXSemiconductor

Assessing Infineon Technologies (XTRA:IFX) Valuation After New €2.0b Bond Issuance

Infineon’s new bond issues and why they matter for equity investors Infineon Technologies (XTRA:IFX) has just raised fresh debt across three new euro bonds, a move that gives the semiconductor group extra flexibility around funding, refinancing, and future investment plans. The company completed fixed income offerings totaling about €2.0b on 12 February 2026, issuing unsubordinated unsecured notes with fixed coupons and staggered maturities in 2031, 2034, and 2037. See our latest analysis for...
XTRA:SAP
XTRA:SAPSoftware

Is There Now An Opportunity In SAP (XTRA:SAP) After The Recent Share Price Pullback

If you are wondering whether SAP's current share price gives you good value for your money, this article will walk through what the numbers actually say rather than just the market noise. SAP recently closed at €167.86, with returns of a 0.3% decline over 7 days, a 15.2% decline over 30 days, a 16.9% decline year to date and a 38.3% decline over 1 year. The 3 year and 5 year returns sit at 61.0% and 76.3% respectively. These moves have put SAP back on many watchlists, as investors reassess...
XTRA:CBK
XTRA:CBKBanks

Assessing Commerzbank (XTRA:CBK) Valuation After Recent Share Price Consolidation

Commerzbank stock overview after recent performance data Commerzbank (XTRA:CBK) is back in focus as investors assess its recent share performance, including a roughly flat move over the past month and a positive total return over the past 3 months. See our latest analysis for Commerzbank. While the share price has eased slightly in the last day, a 5.1% 7 day share price return and 5.7% 90 day share price return contrast with a year to date share price decline, alongside a very large 5 year...
XTRA:LHA
XTRA:LHAAirlines

A Look At Deutsche Lufthansa (XTRA:LHA) Valuation After Sector Weakness And Earnings Uncertainty

Deutsche Lufthansa (XTRA:LHA) is back in focus after a 54.51% share price drop on 23 February 2026, as sector weakness, margin pressure and elevated leverage met rising tension around the 6 March earnings announcement. See our latest analysis for Deutsche Lufthansa. The sharp 54.51% one day share price drop stands in contrast to Deutsche Lufthansa’s 30 day share price return of 4.27% and 1 year total shareholder return of 46.39%. This suggests that recent selling pressure has interrupted what...
XTRA:FME
XTRA:FMEHealthcare

Assessing Fresenius Medical Care (XTRA:FME) Valuation As Earnings Approach And Korea MOU Builds Interest

Investor focus around Fresenius Medical Care (XTRA:FME) is building ahead of its 24 February 2026 earnings release, as the market weighs revenue, margin and regional performance alongside the recent MOU in Korea on high-volume hemodiafiltration. See our latest analysis for Fresenius Medical Care. Recent momentum has been mixed, with a 1 month share price return of 11.20% and a year to date share price return of 3.04%, set against a 1 year total shareholder return decline of 4.60%. This...
XTRA:ENR
XTRA:ENRElectrical

A Look At Siemens Energy (XTRA:ENR) Valuation As Major Shareholders Press For Wind Unit Turnaround

Siemens Energy (XTRA:ENR) is back in focus after its three largest shareholders urged management to fix the loss-making wind turbine unit before any spin off, following a 2025 loss and a recent push from activist Ananym Capital. See our latest analysis for Siemens Energy. The recent push from core shareholders comes after a strong run in Siemens Energy’s share price, with a 30 day share price return of 17.28% and a 1 year total shareholder return of 198.90% highlighting strong momentum. Multi...
XTRA:SIE
XTRA:SIEIndustrials

A Look At Siemens (XTRA:SIE) Valuation As Long Term Returns Outpace Recent Share Performance

With no single headline event driving attention today, Siemens (XTRA:SIE) is drawing interest as investors weigh its recent share performance, current fundamentals, and how its diversified industrial and technology portfolio might fit into broader portfolios. See our latest analysis for Siemens. Siemens’ €240.85 share price comes after a recent 7 day share price return of 2.51%, while a softer 30 day share price return of 5.33% contrasts with a 12.77% 1 year total shareholder return and...
XTRA:SY1
XTRA:SY1Chemicals

Assessing Symrise (XTRA:SY1) Valuation After Launching A €400 Million Share Buyback Program

Symrise (XTRA:SY1) has launched a €400 million share repurchase program. The company aims to buy back up to 10% of its share capital by October 2026, with redeemed shares reducing registered capital. See our latest analysis for Symrise. At a share price of €75.8, Symrise has seen positive short term momentum with a 30 day share price return of 4.44% and a 90 day return of 7.76%. However, the 1 year total shareholder return of 22.03% decline shows longer term holders have faced weaker outcomes...